Gunnar Engström Selected Research

Hemorrhagic Stroke

1/2021	Circulating Growth Differentiation Factor 15 Levels Are Associated With Risk of Both Intracerebral and Subarachnoid Hemorrhage.
4/2006	Risk of stroke and hormone replacement therapy. A prospective cohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gunnar Engström Research Topics

Disease

61	Neoplasms (Cancer) 12/2023 - 01/2002
49	Cardiovascular Diseases (Cardiovascular Disease) 05/2024 - 01/2002
32	Inflammation (Inflammations) 01/2024 - 12/2002
29	Stroke (Strokes) 10/2023 - 02/2003
25	Hypertension (High Blood Pressure) 04/2024 - 12/2002
23	Atherosclerosis 12/2023 - 03/2005
21	Ischemic Stroke 10/2023 - 01/2008
17	Myocardial Infarction 01/2022 - 01/2002
15	Atrial Fibrillation 01/2022 - 11/2010
12	Heart Failure 05/2024 - 02/2009
11	Coronary Artery Disease (Coronary Atherosclerosis) 11/2023 - 01/2014
11	Obesity 12/2022 - 08/2004
10	Insulin Resistance 09/2023 - 12/2006
10	Diabetes Mellitus 12/2021 - 10/2012
9	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 03/2012
6	Type 2 Diabetes Mellitus (MODY) 09/2023 - 01/2014
6	Genetic Risk Score 01/2023 - 01/2016
6	Atherosclerotic Plaque (Atheroma) 12/2022 - 01/2015
6	Chronic Renal Insufficiency 01/2022 - 10/2011
5	Coronary Disease (Coronary Heart Disease) 01/2023 - 07/2004
5	Venous Thromboembolism 10/2022 - 01/2014
5	Peripheral Arterial Disease 07/2021 - 12/2004
5	Breast Neoplasms (Breast Cancer) 01/2021 - 10/2012
5	Abdominal Aortic Aneurysm 01/2021 - 02/2004
4	Carotid Artery Diseases 11/2023 - 12/2017
4	Overweight 01/2021 - 08/2004
4	Embolic Stroke 11/2019 - 01/2014
3	Carotid Stenosis (Carotid Artery Stenosis) 03/2023 - 01/2021
3	Venous Thrombosis (Deep-Vein Thrombosis) 01/2023 - 01/2018
3	Pulmonary Embolism 01/2023 - 01/2018
3	Orthostatic Hypotension (Postural Hypotension) 01/2023 - 11/2010
3	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2021 - 11/2015
3	Rupture 12/2017 - 01/2014
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016 - 11/2011
2	Emphysema 01/2024 - 10/2021
2	Osteoporosis 12/2023 - 01/2014
2	Diabetic Angiopathies (Diabetic Angiopathy) 12/2023 - 01/2019
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 01/2019
2	Hyperglycemia 11/2021 - 05/2015

Drug/Important Bio-Agent (IBA)

33	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2008
17	C-Reactive ProteinIBA 05/2024 - 05/2006
17	Proteins (Proteins, Gene)FDA Link 10/2023 - 12/2002
17	Blood Proteins (Serum Proteins)IBA 03/2021 - 12/2002
15	CadmiumIBA 12/2023 - 01/2014
13	CalciumIBA 04/2024 - 11/2020
11	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2024 - 07/2009
11	Orosomucoid (Seromucoid)IBA 01/2017 - 12/2002
10	HDL CholesterolIBA 10/2023 - 11/2009
10	Ceruloplasmin (Ferroxidase)IBA 01/2017 - 12/2002
10	HaptoglobinsIBA 01/2017 - 12/2002
10	Fibrinogen (Factor I)FDA Link 10/2012 - 12/2002
9	LipidsIBA 10/2023 - 12/2003
9	Cystatin CIBA 01/2022 - 07/2009
8	CholesterolIBA 12/2022 - 01/2007
7	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 10/2004
7	Triglycerides (Triacylglycerol)IBA 11/2022 - 01/2007
7	LDL CholesterolIBA 01/2021 - 11/2009
7	Natriuretic PeptidesIBA 11/2019 - 07/2009
6	CreatinineIBA 01/2024 - 03/2017
6	Urokinase Plasminogen Activator ReceptorsIBA 12/2022 - 01/2014
6	oxidized low density lipoproteinIBA 01/2022 - 11/2009
6	Atrial Natriuretic Factor (ANF)IBA 01/2021 - 11/2010
4	Advanced Glycation End ProductsIBA 12/2023 - 01/2019
4	Antihypertensive Agents (Antihypertensives)IBA 11/2023 - 08/2008
4	SaltsIBA 03/2023 - 03/2011
4	pro-brain natriuretic peptide (1-76)IBA 12/2021 - 11/2010
4	Growth Differentiation Factor 15IBA 10/2021 - 01/2019
4	proadrenomedullinIBA 01/2021 - 07/2009
4	GoldIBA 03/2018 - 03/2012
3	Troponin IIBA 05/2024 - 07/2011
3	Vasopressins (Vasopressin)IBA 01/2024 - 04/2015
3	Amino Acids FDA Link 10/2023 - 03/2013
3	Insulin (Novolin)FDA Link 01/2023 - 08/2014
3	Hemoglobins (Hemoglobin)IBA 11/2022 - 08/2002
3	Peptides (Polypeptides)IBA 01/2022 - 08/2015
3	EnzymesIBA 01/2022 - 07/2012
3	AnticoagulantsIBA 01/2022 - 11/2019
3	Caspase 3 (Caspase-3)IBA 10/2021 - 01/2017
3	proneurotensinIBA 01/2021 - 10/2012
3	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2021 - 01/2017
3	Complement C3 (C3 Complement)IBA 01/2019 - 06/2007
3	Caspase 8 (Caspase-8)IBA 01/2018 - 01/2017
3	Hormones (Hormone)IBA 11/2017 - 04/2006
3	Growth Hormone (Somatotropin)IBA 10/2017 - 10/2014
3	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2017 - 04/2014
2	Troponin T (Troponin T1)IBA 05/2024 - 12/2021
2	Carbon MonoxideIBA 03/2024 - 03/2005
2	Interleukin-6 (Interleukin 6)IBA 10/2023 - 01/2016
2	FollistatinIBA 09/2023 - 11/2021
2	Estrogens (Estrogen)FDA Link 01/2023 - 04/2006
2	Interleukin-8 (Interleukin 8)IBA 01/2023 - 01/2016
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 12/2022 - 01/2014
2	factor V LeidenIBA 01/2022 - 01/2018
2	Immunoglobulin M (IgM)IBA 01/2022 - 01/2018
2	omega-Chloroacetophenone (Mace)IBA 01/2022 - 08/2021
2	Air Pollutants (Pollutants, Air)IBA 01/2022 - 12/2020
2	ProteomeIBA 01/2022 - 12/2019
2	Genetic Markers (Genetic Marker)IBA 01/2021 - 12/2017

Therapy/Procedure

10	Therapeutics 10/2023 - 04/2006
3	Hormone Replacement Therapy (Therapy, Hormone Replacement) 08/2014 - 01/2002